The value of [18F]fluoro-2-deoxy-?-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment
Author:
- 1 February 2003
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 39 (2) , 151-157